Episurf Episurf
  • English
  • Swedish
  • German
  • Home
  • Career
  • Contact us
  • Media
  • µiFidelity
  • Patients
  • Healthcare Professionals
  • Investors
  • About Episurf
  • News
  • Newsletter
  • EPIC-Knee
  • Home
  • Career
  • Contact us
  • Media
  • µiFidelity
  • English
  • Swedish
  • German

1 Jan 70
Change in number of shares and votes in Episurf Medical
1 Jan 70
New Australian patent approval for Episurf Medical
1 Jan 70
First Canadian patent approval for Episurf Medical
1 Jan 70
Episurf Medical will exhibit at the 2018 SOF Congress, held in Karlstad, Sweden, on August 27-31
1 Jan 70
New Australian patent approval for Episurf Medical
1 Jan 70
Episurf Medical to present at Börsveckans Småbolagsdag, held in Stockholm, September 5
1 Jan 70
New Australian patent approval for Episurf Medical
1 Jan 70
New US patent approval for Episurf Medical
1 Jan 70
Episurf Medical has received initial feedback from the US FDA on the IDE application for the Episealer® knee implant
1 Jan 70
INTERIM REPORT 1 APRIL– 30 JUNE 2018

Posts navigation

Older posts
Newer posts
  • Facebook
  • YouTube
  • Twitter
  • LinkedIn

ADDRESS Episurf Medical AB, Karlavägen 60, 114 49 Stockholm. Sweden

CONTACT info@episurf.com +46 (0)8 612 00 20

© Episurf 2023
By clicking or navigating this page, you agree to allow the use of cookies.Agree